Alan Auerbach Net Worth

1 week from now

Alan Auerbach is a successful American entrepreneur who has achieved two major successes in the biotech sector. In 2009, Johnson & Johnson purchased Cougar Biotechnology, a cancer drug company founded by Auerbach, for approximately $1 billion in cash, netting Auerbach an estimated $50 million. In 2014, shares of his latest business, Puma Biotechnology, skyrocketed following positive news from a late stage clinical trial of a breast cancer drug. Auerbach holds a bachelor's and master's degree in biomedical engineering and began his career as a research analyst covering biotech companies in Los Angeles.
Alan Auerbach is a member of Medicine

Age, Biography and Wiki

Birth Place

United States

💰 Net worth: $1.2 Billion (2024)

Alan Auerbach's net worth is estimated to be $1.2 billion in 2024. He is widely recognized as a prominent figure in the field of medicine in the United States. Known for his contributions to the healthcare industry, Auerbach has earned significant wealth through his successful career. His expertise and groundbreaking work have undoubtedly played a crucial role in shaping the medical landscape, offering innovative solutions and advancements to enhance patient care. With his remarkable net worth, Alan Auerbach continues to make a lasting impact in the field of medicine, revolutionizing the way we approach healthcare.

2014 $1.55 Million

2015 $1.2 Million

2018 $1.2 Million

Biography/Timeline

1992

Auerbach is a fellow of the American Academy of Arts and Sciences and of the Econometric Society. He was the Deputy Chief of Staff of the U.S. Join Committee on Taxation in 1992.

Some Alan Auerbach images

Tags Living people American economists Harvard University alumni University of California, Berkeley faculty Harvard University faculty University of Pennsylvania faculty Fellows of the American Academy of Arts and Sciences